Mark J Pirwitz MD
Interventional Cardiology
Associate Professor; Chief Division of Cardiology; University of Texas Dell Medical School; Austin, TX
Join to View Full Profile
1301 W 38th StSte 400Austin, TX 78705
Phone+1 512-324-3440
Fax+1 512-406-6513
Dr. Pirwitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Missouri-Kansas City School of MedicineFellowship, Interventional Cardiology, 1995 - 1996
University of Texas Southwestern Medical CenterFellowship, Cardiovascular Disease, 1992 - 1995- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1989 - 1992
University of Texas Southwestern Medical SchoolClass of 1989
Certifications & Licensure
TX State Medical License 1990 - 2026
ID State Medical License 2005 - 2013
WA State Medical License 2005 - 2012
PA State Medical License 2011 - 2011
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 5 citationsPatient-Specific Quantitative In-Vivo Assessment of Human Mitral Valve Leaflet Strain Before and After MitraClip Repair.Natalie T Simonian, Hao Liu, Sneha Vakamudi, Mark J Pirwitz, Alison M Pouch
Cardiovascular Engineering and Technology. 2023-10-01 - 8 citationsThe Market Reacts Quickly: Changes in Paclitaxel Vascular Device Purchasing Within the Ascension Healthcare System.Peter Monteleone, Subhash Banerjee, Priya Kothapalli, Ariel Dora Stern, Daniel C. Fehder
The Journal of Invasive Cardiology. 2020-01-01 - 3 citationsIntracardiac shunts resulting from transseptal catheterization for ablation of accessory pathways in otherwise normal hearts.David J. Kessler, Mark J. Pirwitz, Rodney Horton, Robert Canby, Patrick J. Welch
The American Journal of Cardiology. 1998-08-01
Press Mentions
Priya Kothapalli, MDJanuary 3rd, 2023- Ascension Seton Launches Cardio-Oncology Program in AustinNovember 27th, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
